Login / Signup
Su Jin Lim
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 3
Top Topics
Chemotherapy Induced
Small Cell Lung Cancer
Phase Ii Study
Clinical Trial
Top Venues
Cancer research communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Helen Catherine Wilbur
,
Jennifer N Durham
,
Su Jin Lim
,
Katrina Purtell
,
Katherine M Bever
,
Daniel A Laheru
,
Ana M C De Jesus-Acosta
,
Nilofer S Azad
,
Bradley Wilt
,
Luis A Diaz
,
Dung T Le
,
Hao Wang
Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer.
Cancer research communications
3 (8) (2023)
Eric S Christenson
,
Su Jin Lim
,
Jennifer N Durham
,
Ana M C De Jesus-Acosta
,
Katherine M Bever
,
Daniel A Laheru
,
Amy Ryan
,
Parul Agarwal
,
Robert B Scharpf
,
Dung T Le
,
Hao Wang
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma.
Cancer research communications
2 (11) (2022)
Eric S Christenson
,
Su Jin Lim
,
Jennifer N Durham
,
Ana M C De Jesus-Acosta
,
Katherine M Bever
,
Daniel A Laheru
,
Amy Ryan
,
Parul Agarwal
,
Robert B Scharpf
,
Dung T Le
,
Hao Wang
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma.
Cancer research communications
2 (11) (2022)